Sailesh Mohan

Sailesh Mohan

Professor at the Public Health Foundation India
Joint Director of the Centre for Chronic Conditions and Injuriies
Sailesh
Dr. Sailesh Mohan is an Honorary Professor at the Deakin University, Melbourne, Australia, Honorary Senior Scientist at the Centre for Chronic Disease Control (CCDC), Delhi and the India Site Director for the HBNU NIH-Fogarty Global Health Training Program to train post-doctoral scholars.   Dr. Mohan is involved in NCD research, teaching, and training. He leads various NCD research projects and current work is focused on: (a) developing, implementing, and evaluating sustainable comprehensive community and health system-based approaches/care models for hypertension and diabetes prevention and control as well as multimorbidity or multiple long-term conditions (b) improving food systems by providing policy-makers with interdisciplinary scientific evidence on how food systems can deliver nutritious foods sustainably and equitably, and (c) training/mentoring junior researchers through training programs to undertake research and improve NCD prevention and control in India and other low-middle income countries. 
In addition to research/teaching Dr. Mohan also contributes to NCD policy endeavors in India by working with the World Health Organization (WHO) and serving as a member of influential policy-making committees of the WHO and Government of India on NCD prevention and control. He has been a recipient of the CIHR Canada HOPE Fellowship Award, selected as an “Emerging Leader” of the World Heart Federation’s initiative aimed to reduce premature mortality from NCDs by 2025 and also selected to the US-NIH supported “Public Health Leader” program of Emory University, that aims to develop the next generation of innovative and committed developing country public health leaders to address NCDs. He has published and presented extensively on NCDs and has successfully obtained peer reviewed grant funding from most of the leading global research agencies, with an active funding of over 18 million USD as co-investigator or principal investigator.